Pharma Marketing News Vol. 10, No. 5: 10 MARCH 2011

Welcome to Volume 10, Issue #5 (10 MARCH 2011) of Pharma Marketing News.

AstraZeneca Hosts First-Ever Twitter Chat

Despite dire predictions of 'PR failure,' the #rxsave Twitter chat hosted by @AstraZenecaUS on 15 February 2011 was a great success, which is pharma social media speak for 'did not crash and burn.' It was proof that a pharmaceutical company can indeed host meaningful Twitter chats.

Pharma Marketing News Vol. 10, No. 7: 15 April 2011

Welcome to Volume 10, Issue #7 (15 APRIL 2011) of Pharma Marketing News.

Pharma Marketing News Vol. 10, No. 3: 17 FEBRUARY 2011

Welcome to Volume 10, Issue #3 (17 FEBRUARY 2011) of Pharma Marketing News.

GSK’s U.S. Sales Reps “Europeanized”: No Longer Rewarded for Ability to Push Prescriptions

An anonymous poster to CafePharma described what the

British Pharma Digital Update: Insider Reactions to Social Media Guidelines from Industry Regulators

This article reports the results of an informal Weber Shandwick survey regarding social media guidelines recently published by the British pharmaceutical industry regulators. It includes advice for how to innovate online without waiting for more specific guidelines from regulators.

Brits Beat FDA and PhRMA: Issue Social Media Guidance for Pharma

Prescription Medicines Code of Practice Authority Issues Social Media Guidance for Pharma. The Brits have won the race to issue social media guidance for the drug industry! In April, 2011, the Prescription Medicines Code of Practice Authority (PMCPA), which oversees the self-regulatory code of the Association of the British Pharmaceutical Industry (ABPI), published 'informal guidance' providing the drug industry advice on how to use online communications.

Are Sales Reps as “Useful” as PhRMA Wants Us to Believe?

Let's Look at Some Data PhRMA Doesn't Mention. PhRMA pointed out that nearly 9 out of 10 physicians considered company-sponsored peer education programs to be 'up-to-date, useful and reliable.'

Vast Majority of Drug Ads in Leading Medical Journals Don’t Pass MDs’ Sniff Test!

A study led by Mount Sinai School of Medicine researchers of 192 pharmaceutical advertisements (83 full unique advertisements) in biomedical journals found that only 18 percent (15) were compliant with Food and Drug Administration (FDA) guidelines, and over half failed to quantify serious risks including death.

Breaking the 140-character Limit of Twitter

Opening the Door to FDA-Compliant Branded Tweets: Deck.ly has enormous potential for pharmaceutical marketers who have been chaffing at the bit to post meaningful branded messages via Twitter but who have been stymied by lack of guidance from FDA regarding how to provide fair balance within the 140-character limit of Twitter.

STAY CONNECTED

29,540FollowersFollow
- Advertisement -